Pudong Innotek
Overview
Pudong Innotek is a venture capital firm based in Shanghai, China, specializing in early-stage investments within the technology and healthcare sectors. The firm focuses on identifying and supporting innovative companies that demonstrate strong growth potential and align with its strategic investment criteria. The firm's investment strategy encompasses a range of stages, including Seed, Series A, and Series B rounds, with typical investment sizes ranging from $5 million to $50 million. Pudong Innotek has a geographical focus on China and the United States, seeking opportunities in both domestic and international markets. Pudong Innotek's portfolio includes investments in biotechnology, healthcare, pharmaceuticals, therapeutics, and biopharma industries. The firm has a track record of supporting companies that are at the forefront of innovation in these sectors, contributing to advancements in medical treatments and technologies.
Investment Focus
- Innovative technology solutions
- Strong management teams
- Scalable business models
- Clear path to profitability
Portfolio Companies
Reach Pudong Innotek directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Pudong Innotek
What sectors does Pudong Innotek invest in?
Pudong Innotek invests in Healthcare, Pharmaceuticals, Biotechnology, Therapeutics and Biopharma, and is based in China. Pudong Innotek is listed as a venture capital in the ConnectSafely investor database.
What stage does Pudong Innotek invest at?
Pudong Innotek backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 5M - 50M.
Which regions does Pudong Innotek invest in?
Pudong Innotek invests across United States and China.
What companies has Pudong Innotek invested in?
Pudong Innotek's portfolio includes Hepanova.
Last updated · Source: ConnectSafely investor database
